Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
05/2003
05/28/2003EP1313843A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/28/2003EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof
05/28/2003EP1313506A1 Immunologic method for the prevention of dental caries
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP0988048A4 Ligand/lytic peptide compositions and methods of use
05/28/2003DE20304619U1 Snail fence for preventing snails from reaching vegetable patches or flower beds, comprises mesh-shaped wiring layer coved by textile layer
05/28/2003CN2552339Y Multifunctional high efficient dual-purpose plastic silk-raising utensil
05/28/2003CN1419821A Temp-sensitive lethality male silkworm breeding method
05/28/2003CN1419820A Large liver duck feeding method
05/28/2003CN1419819A Method for industrial cage farming egg ducks
05/28/2003CN1109495C Raising method of fryer
05/27/2003US6570061 Generating transgenic animal; obtain animal blastocyst, transform with expression vector coding immunoglobulin, propagate blastocyst and recover trangenic animal
05/27/2003US6569679 Recombinant viral vector capable of expressing a gene product that activates a non-cytotoxic compound into a toxic product; use in treatment of viral diseases, cancer, genetic diseases
05/27/2003US6569666 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
05/27/2003US6568351 Methods for raising rabbits
05/22/2003WO2003042401A2 Novel chromophores/fluorophores and methods for using the same
05/22/2003WO2003042386A1 Desmin gene having novel point mutation causative of dilated cardiomyopathy
05/22/2003WO2003042382A1 ES CELLS WITH ENHANCED RNAi EFFECT
05/22/2003WO2003042366A2 A novel saitohin gene and uses of same
05/22/2003WO2003041659A2 Method and identification of downstream mrna ligands to fmrp and their role in fragile x syndrome and associated disorders
05/22/2003WO2003041496A1 Transgenic animal
05/22/2003WO2003041495A1 Chimeric nonhuman animal
05/22/2003WO2003008554A3 Methods and compositions for cell therapy
05/22/2003WO2002053740A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/22/2003WO2002052930A3 Control of sex determination in mammals
05/22/2003WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002022776A9 Human coagulation factor vii variants
05/22/2003US20030097671 Inhibition of betaarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
05/22/2003US20030097670 For producing and isolating homogeneous proteins
05/22/2003US20030097669 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
05/22/2003US20030097667 For therapy of Alzheimers disease, diagnosis
05/22/2003US20030097665 To produce phosphorylated lysosomal proteins which are incorporated into pharmaceutical formulations for use in enzyme replacement therapy
05/22/2003US20030096319 Method of sorting birds
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030095967 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
05/22/2003US20030094138 Method of producing avian eggs and birds of germ-free status
05/22/2003CA2466420A1 A novel saitohin gene and uses of same
05/22/2003CA2465337A1 Transgenic animal
05/22/2003CA2454031A1 Novel chromophores/fluorophores and methods for using the same
05/21/2003EP1312259A1 Type iii allergic inflammation model animal
05/21/2003EP1311704A2 Novel target genes for diseases of the heart
05/21/2003EP1311692A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
05/21/2003EP1311667A2 Transgenic animal model for neurodegerative disease and uses thereof
05/21/2003EP1311661A2 Enhanced homologous recombination mediated by lambda recombination proteins
05/21/2003EP1311530A2 Production of humanized antibodies in transgenic animals
05/21/2003EP1311298A2 System for regulating in vivo the expression of a transgene by conditional inhibition
05/21/2003EP1311153A2 High temperature cryogenic preservation of biologically active material
05/21/2003EP0845939B1 Lysosomal proteins produced in the milk of nonhuman transgenic animals
05/21/2003CN1419413A Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof
05/21/2003CN1419409A Methods for gamete production in birds
05/21/2003CN1418953A Specific expression of human leptin protein in egg white
05/21/2003CN1418543A Method for utilization of biological reaction device specially used for variety development of silkworm
05/21/2003CN1418542A Method for cultivating novel species of Huliotis discus hannai Ino with tangerine color shell
05/21/2003CN1418541A Method for raising female animals for increasing their milk prodn.
05/21/2003CN1109136C Production of colored silk filament
05/20/2003US6566582 Animal model for use in the diagnosis and treatment of cancer
05/20/2003US6566581 Animal model for use in the diagnosis and treatment of lung cancer
05/20/2003US6566324 Preventing airway mucus production by administration of EGF-R antagonists
05/20/2003US6566092 Nucleotide sequences coding polypeptide for use in the treatment nervous system disorders
05/15/2003WO2003040359A1 Preparing somatic embryo by utilizing rabbit oocyte
05/15/2003WO2003040353A1 A novel stem cell with long-term growth potential, methods of culturing and animals derived therefrom
05/15/2003WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003WO2003039245A2 Transgenic mice knockout for histamine receptor h3 gene
05/15/2003WO2003004626A3 A bioprocess for the generation of cells derived from spheroid-forming cells
05/15/2003WO2002048366A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002048365A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002009509A3 Inhibition of gene expression using polynucleotide analogues
05/15/2003US20030093822 Transgenic animal model of neurodegenerative disorders
05/15/2003US20030093821 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol
05/15/2003US20030093820 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
05/15/2003US20030093818 Transgenic animals comprising a humanized immune system
05/15/2003US20030092624 Denaturant (boiling and/or detergent) stable; various uses including de-aggregating and/or preventing aggregation of an aggregating protein such as beta-amyloid or prions, restoring enzyme activity, and immunization using fusion protein
05/15/2003US20030092157 Compositions, screening systems and methods for modulating HDL cholesterol and triglyceride levels
05/15/2003US20030092025 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment, prevention of tumor disorders
05/15/2003US20030091995 Generation of human antibody display library; obtain trangenic animal, transform with nucleotide sequence which code antibodies, form library of display packages displaying antibody chains
05/15/2003US20030091977 Assessment method
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091561 Anticancer agents
05/15/2003CA2466203A1 Cross-species somatic cell nuclear transfer using rabbit oocyte
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310166A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function
05/14/2003EP1310165A1 Method for reproducing and rearing Silurus Glanis in particular in aquatic medium and implementing device
05/14/2003EP1309727A2 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease
05/14/2003EP1309713A2 Methods for raising rabbits
05/14/2003EP1309706A2 Modulation of stem cell differentiation
05/14/2003EP1309699A2 Elongase genes and uses thereof
05/14/2003EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309678A2 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed
05/14/2003EP1309341A2 Prevention and treatment of alzheimer's disease
05/14/2003EP0958382B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
05/14/2003CN1416696A Gravity-free condition simulating method and apparatus of treating tertilized egg of aquatic animal
05/14/2003CN1416695A Breeding method of black-shin yellow chicken
05/13/2003WO2004039826A1 Anti-il-6 antibodies, compositions, methods and uses